Showing results (2041-2050 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|March 5, 2003
Impact of current transplantation practices on the changing epidemiology of infections in transplant recipientsNina Singh
The Lancet. Infectious Diseases|July 3, 2003
How best to estimate the global burden of pertussis?N S Crowcroft, C Stein, P Duclos, et al.
The Lancet. Infectious Diseases|November 10, 2021
The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in SwedenCharlotta Edlund, Anders Ternhag, Gunilla Skoog Ståhlgren, et al.
The Lancet. Infectious Diseases|November 15, 2021
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trialStephen E Goldstone, Anna R Giuliano, Joel M Palefsky, et al.
The Lancet. Infectious Diseases|February 16, 2019
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trialMichael Povey, Ouzama Henry, Marianne A Riise Bergsaker, et al.
The Lancet. Infectious Diseases|April 1, 2019
Institutional trust and misinformation in the response to the 2018-19 Ebola outbreak in North Kivu, DR Congo: a population-based surveyPatrick Vinck, Phuong N Pham, Kenedy K Bindu, et al.
The Lancet. Infectious Diseases|April 2, 2019
Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak reportRindra Randremanana, Voahangy Andrianaivoarimanana, Birgit Nikolay, et al.
The Lancet. Infectious Diseases|February 23, 2019
The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet. Infectious Diseases|August 28, 2019
Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trialsSimone Lanini, John P A Ioannidis, Francesco Vairo, et al.
The Lancet. Infectious Diseases|September 28, 2019
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialJyh-Ming Liou, Chieh-Chang Chen, Chih-Min Chang, et al.
Pageof 270